Stem Cell Therapy advancements, page-370

Well, whether you want to call me trader or investor (but after 8 years of a steadily growing position since IPO I think I qualify as an investor), I bought more this morning at $0.41.

I have suggested on here numerous times to buy on the wanes like this between announcements rather than the higher prices on announcements. A lower buy average like this makes these predictable falls between announcements more palatable.

Guys, can we keep this thread for stem cell therapies and perhaps move the share price dissatisfaction/criticisms to the trading thread?

In that vein something I have been crowing on about here forever, the use of biologics like Ortho ATI in augmenting rotator cuff and other orthopedic repairs to improve efficacy:

https://medicalxpress.com/news/2022-12-stem-cells-shoulder-surgery.html